X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9542) 9542
Publication (800) 800
Newsletter (228) 228
Book Review (83) 83
Newspaper Article (38) 38
Book Chapter (26) 26
Conference Proceeding (10) 10
Magazine Article (9) 9
Dissertation (7) 7
Data Set (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5305) 5305
dexamethasone (4677) 4677
male (3847) 3847
animals (3569) 3569
female (3339) 3339
index medicus (3263) 3263
dexamethasone - pharmacology (2955) 2955
middle aged (1962) 1962
adult (1872) 1872
dexamethasone - administration & dosage (1726) 1726
rats (1707) 1707
aged (1502) 1502
oncology (1279) 1279
dexamethasone - therapeutic use (1199) 1199
mice (1027) 1027
multiple myeloma - drug therapy (1019) 1019
treatment outcome (1017) 1017
hematology (996) 996
thalidomide - analogs & derivatives (971) 971
pharmacology & pharmacy (959) 959
multiple myeloma (924) 924
antineoplastic combined chemotherapy protocols - therapeutic use (914) 914
steroids (826) 826
dexamethasone - analogs & derivatives (794) 794
cells, cultured (742) 742
glucocorticoids - pharmacology (723) 723
endocrinology & metabolism (694) 694
care and treatment (689) 689
corticosteroids (683) 683
bortezomib (681) 681
dose-response relationship, drug (672) 672
glucocorticoids (668) 668
biochemistry & molecular biology (637) 637
chemotherapy (632) 632
analysis (609) 609
lenalidomide (606) 606
research (599) 599
time factors (597) 597
thalidomide - administration & dosage (596) 596
therapy (584) 584
expression (555) 555
aged, 80 and over (526) 526
cancer (521) 521
thalidomide (519) 519
surgery (507) 507
adolescent (505) 505
thalidomide - therapeutic use (501) 501
medicine & public health (491) 491
cell line (477) 477
double-blind method (462) 462
drug therapy, combination (455) 455
pain (450) 450
neurosciences (441) 441
dexamethasone - adverse effects (429) 429
cell biology (423) 423
prospective studies (416) 416
drug therapy (411) 411
cells (405) 405
antineoplastic combined chemotherapy protocols - adverse effects (399) 399
receptors, glucocorticoid - metabolism (393) 393
kinetics (392) 392
stem-cell transplantation (377) 377
rats, sprague-dawley (370) 370
clinical trials (365) 365
antineoplastic agents - therapeutic use (364) 364
inflammation (362) 362
immunology (357) 357
health aspects (353) 353
apoptosis (352) 352
dexamethasone - metabolism (347) 347
survival (345) 345
glucocorticoids - administration & dosage (340) 340
dosage and administration (329) 329
plus dexamethasone (323) 323
prevention (322) 322
thalidomide - adverse effects (321) 321
article (318) 318
recurrence (315) 315
multiple myeloma - pathology (314) 314
pregnancy (312) 312
in-vitro (307) 307
nausea (307) 307
rats, wistar (307) 307
anti-inflammatory agents - pharmacology (305) 305
abridged index medicus (300) 300
central nervous system depressants (299) 299
hydrocortisone - blood (296) 296
rats, inbred strains (293) 293
prednisolone - analogs & derivatives (290) 290
anti-inflammatory agents - therapeutic use (289) 289
young adult (285) 285
efficacy (283) 283
double-blind (280) 280
in vitro techniques (278) 278
activation (277) 277
glucocorticoids - therapeutic use (277) 277
anti-inflammatory agents - administration & dosage (276) 276
child (266) 266
rna, messenger - metabolism (266) 266
gene-expression (265) 265
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9273) 9273
French (115) 115
German (105) 105
Japanese (81) 81
Italian (53) 53
Spanish (50) 50
Chinese (49) 49
Russian (31) 31
Polish (24) 24
Czech (10) 10
Dutch (7) 7
Korean (6) 6
Portuguese (6) 6
Persian (5) 5
Hungarian (4) 4
Norwegian (2) 2
Swedish (2) 2
Turkish (2) 2
Arabic (1) 1
Hebrew (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Urology, ISSN 0090-4295, 2004, Volume 63, Issue 1, pp. 120 - 125
Objectives. To evaluate prospectively the combination of a luteinizing hormone-releasing hormone analog with a somatostatin analog and dexamethasone in... 
ETOPOSIDE | THERAPY | ORAL ESTRAMUSTINE | CLINICAL-TRIALS | DISEASE | UROLOGY & NEPHROLOGY | CASTRATION | CARCINOMA | CELL-DEATH | Somatostatin - adverse effects | Estramustine - administration & dosage | Humans | Middle Aged | Somatostatin - administration & dosage | Bone Neoplasms - secondary | Dexamethasone - adverse effects | Male | Triptorelin Pamoate - administration & dosage | Life Tables | Peptides, Cyclic - administration & dosage | Antineoplastic Agents, Hormonal - adverse effects | Aged, 80 and over | Bone Neoplasms - drug therapy | Gonadotropin-Releasing Hormone - agonists | Prostatic Neoplasms - drug therapy | Hematologic Diseases - chemically induced | Somatostatin - analogs & derivatives | Dexamethasone - administration & dosage | Etoposide - adverse effects | Prostatic Neoplasms - surgery | Antineoplastic Agents, Hormonal - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | Triptorelin Pamoate - adverse effects | Combined Modality Therapy | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Prostatic Neoplasms - mortality | Orchiectomy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Diabetes Mellitus - chemically induced | Aged | Estramustine - adverse effects | Peptides, Cyclic - adverse effects | Gastrointestinal Diseases - chemically induced | Adenocarcinoma - mortality | Adenocarcinoma - surgery
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2011, Volume 17, Issue 16, pp. 5311 - 5321
Journal Article
Blood, ISSN 0006-4971, 11/2006, Volume 108, Issue 10, pp. 3458 - 3464
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 2, pp. 142 - 152
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2009, Volume 27, Issue 34, pp. 5713 - 5719
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2016, Volume 375, Issue 14, pp. 1319 - 1331
Journal Article
Leukemia, ISSN 0887-6924, 2014, Volume 28, Issue 8, pp. 1573 - 1585
Journal Article
Hematological Oncology, ISSN 0278-0232, 12/2013, Volume 31, Issue 4, pp. 213 - 217
Angioimmunoblastic T‐cell lymphoma (AITL) is characterized by an aggressive clinical course and unfavourable prognosis. Refractory AITL patients have very few... 
chemorefractory | lenalidomide | AITL | salvage treatment | Chemorefractory | Salvage treatment | Lenalidomide | PHASE-II TRIAL | ACTIVATION | ONCOLOGY | THALIDOMIDE ANALOGS | HEMATOLOGY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Clinical Trials as Topic - statistics & numerical data | Follow-Up Studies | Humans | Middle Aged | Salvage Therapy | Drugs, Investigational - therapeutic use | Drug Resistance, Neoplasm | Male | Vinblastine - administration & dosage | Thalidomide - analogs & derivatives | Organoplatinum Compounds - administration & dosage | Vinblastine - analogs & derivatives | Doxorubicin - analogs & derivatives | Angiogenesis Inhibitors - therapeutic use | Doxorubicin - administration & dosage | Lymphoma, T-Cell, Peripheral - drug therapy | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Deoxycytidine - administration & dosage | Combined Modality Therapy | Lymphoma, T-Cell, Peripheral - radiotherapy | Remission Induction | Cytarabine - administration & dosage | Polyethylene Glycols - administration & dosage | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Thalidomide - therapeutic use | Deoxycytidine - analogs & derivatives | Immunologic Factors - therapeutic use | T cells | Radiotherapy | Lymphomas
Journal Article
Cell Metabolism, ISSN 1550-4131, 10/2017, Volume 26, Issue 4, pp. 620 - 632.e6
Journal Article